| Net Cash Provided by (Used in) Operating Activities |
-1.77M |
USD |
-3236% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
5.2M |
USD |
+7033% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
250M |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
11M |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
9.6M |
USD |
+48107% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
376K |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
3.52M |
USD |
+31.2% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
3.52M |
USD |
+31.2% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-520K |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
2.77M |
USD |
+35.5% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
24.8M |
shares |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
31.5M |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
1.04M |
USD |
|
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
30.9K |
USD |
-25.1% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |